Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on March 27, 2026

Mar. 27, 2026

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label

Indeterminate GlobeNewswire

Mar. 27, 2026

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

Indeterminate GlobeNewswire

Mar. 27, 2026

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire

Mar. 27, 2026

Arletta Pharma Solutions Announces Positive Results from Phase II Clitoral Doppler Duplex Ultrasound Study of Lybrido™ Combination Targeting Female Sexual Dysfunction

Indeterminate GlobeNewswire

Mar. 27, 2026

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

Indeterminate GlobeNewswire

Mar. 27, 2026

Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Indeterminate GlobeNewswire

Mar. 27, 2026

Precision Optics Corporation, Inc. Announces Pricing of Upsized $10 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

Mar. 27, 2026

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Indeterminate GlobeNewswire

Mar. 27, 2026

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

Indeterminate GlobeNewswire

Mar. 27, 2026

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 27, 2026

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

Indeterminate GlobeNewswire

Mar. 27, 2026

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Indeterminate GlobeNewswire

Mar. 27, 2026

Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Mar. 27, 2026

ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

Indeterminate GlobeNewswire

Mar. 27, 2026

BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting

Indeterminate GlobeNewswire

Mar. 27, 2026

Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs

Indeterminate GlobeNewswire

Mar. 27, 2026

Crinetics Pharmaceuticals Solicita Autorização de Comercialização de Palsonify™ (Paltusotina) no Brasil para Tratamento de Acromegalia

Indeterminate GlobeNewswire

Mar. 27, 2026

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

Indeterminate GlobeNewswire

Mar. 27, 2026

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

Indeterminate GlobeNewswire

Mar. 27, 2026

Gelatine Sculpt Claims Evaluated: Documenting the Gelatin Trick Recipe Investigation for Consumer Safety

Indeterminate GlobeNewswire